European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

European equities traded in the US as American depositary receipts were trending higher Monday, rising 0.84% to 1,428.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which increased 9.3% and 3.3% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and pharmaceutical company Sanofi (SNY), which were up 2.8% and 3% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and medical device maker EDAP TMS (EDAP), which fell 5.7% and 1.3% respectively. They were followed by furniture maker Natuzzi (NTZ) and telecommunications company VEON (VEON), which dropped 0.2% and 1.3% respectively.

From the UK and Ireland, the gainers were led by insurance firm Prudential (PUK) and biopharmaceutical company Amarin (AMRN), which increased 7.9% and 7.4% respectively. They were followed by biopharmaceutical company Verona Pharma plc (VRNA) and tobacco company British American Tobacco (BTI), which were up 3.4% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which fell 6.6% and 0.3% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO) 2.2% and 1.3% respectively.